Robert James Glynn, Sc.D., Ph.D.
Co-Author
This page shows the publications co-authored by Robert Glynn and Katsiaryna Bykov.
Connection Strength
0.644
-
A Case-Crossover-Based Screening Approach to Identifying Clinically Relevant Drug-Drug Interactions in Electronic Healthcare Data. Clin Pharmacol Ther. 2019 07; 106(1):238-244.
Score: 0.202
-
The Case-Crossover Design for Drug-Drug Interactions: Considerations for Implementation. Epidemiology. 2019 03; 30(2):204-211.
Score: 0.201
-
Updating the Evidence of the Interaction Between Clopidogrel and CYP2C19-Inhibiting Selective Serotonin Reuptake Inhibitors: A Cohort Study and Meta-Analysis. Drug Saf. 2017 10; 40(10):923-932.
Score: 0.182
-
Coprescription of Opioids With Other Medications and Risk of Opioid Overdose. Clin Pharmacol Ther. 2021 10; 110(4):1011-1017.
Score: 0.059
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.